Background The purpose of this study was to assess the efficacy and safety between
tenofovir and entecavir in the treatment of CHB and HBV related cirrhosis through Meta …

Recent progress in our understanding of the pathways linked to progression from hepatic
insult to cirrhosis has led to numerous novel therapies being investigated as potential cures …

Keyur Patel1, Sumeet K Asrani2, Maria Isabel Fiel3, Deborah Levine4, Daniel H. Leung5,
Andres Duarte-Rojo6, Jonathan A. Dranoff7 Page 1 Accuracy of blood-based biomarkers for …

Several markers and prognostic scores have been identified for predicting the development
and progression of liver disease; among them, haematological parameters (the neutrophil to …

This study is aimed at evaluating the diagnostic value of FIB-4 for liver fibrosis in patients
with hepatitis B through a meta-analysis of diagnostic test. We conducted a comprehensive …

Background: Red cell volume distribution width to platelet ratio (RPR), as a novel
noninvasive assessment, is frequently investigated. However, the utility of RPR to evaluate …

Abstract Background and Aim Antiviral therapy (AVT) induces fibrosis regression in patients
with chronic hepatitis B. We investigated long‐term effects of entecavir (ETV) versus …

A series of predictive scoring systems is available for stratifying the severity of conditions
and assessing the prognosis in patients with HBV‐related liver diseases. We show nine of …

Background No studies have investigated the predictive and monitoring efficacy of aspartate
aminotransferase to platelet ratio index in chronic hepatitis B patients undergoing antiviral …

Background Recent research has closely linked adipocytokines to liver inflammation and
fibrosis progression in patients with non-alcoholic liver disease. This study aimed to …